Skip to main content

Advertisement

Table 1 The characteristics of IM patients

From: Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients

  MILD IM-HLH or IM-CAEBV P-value
(n = 31) (n = 7)  
Gender >o.o5
 male 18(58.1%) 3(42.9%)  
 female 13(41.9%) 4(57.1%)  
Age >o.o5
 0–14 24(77.4%) 5(71.4%)  
 >14 7(22.6%) 2(28.6%)  
Leukocyte count >o.o5
 4 × 109/L 7(22.6%) 2(28.6%)  
 4–10 × 109/L 8(25.8%) 1(14.3%)  
 ≥10 × 109/L 16(51.6%) 4(57.1%)  
 Median(range) 10.85(1.2–43.0) 14.9(1.5–61.0)  
ALT or AST >o.o5
 high 27(87.1%) 7(100%)  
 normal/low 4(12.9%) 0(0%)  
coagulopathy >o.o5
 positive 22(74.2%) 6(85.7%)  
 negative 9(25.8%) 1(14.3%)  
ferritin high >o.o5
 high 24(77.4%) 6(85.7%)  
 normal/low 7(22.6%) 1(14.3%)  
Triglyceride >0.05
 high 24(77.4%) 6(85.7%)  
 normal/low 7(22.6%) 1(14.3%)  
hepatosplenomegaly >o.o5
 yes 22(71.0%) 6(85.7%)  
 no 9(29.0%) 1(14.3%)  
lymphoadenopathy    >o.o5
 yes 24(77.4%) 5(71.4%)  
 no 7(22.6%) 2(28.6%)  
Days after onset of disease <o.o5
 average time 34.8d 119.7d(4/7, 3 decreased)